Global Blood-Grouping Reagents Market 2022-2026

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publishers market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth. The publisher has been monitoring the blood-grouping reagents market and it is poised to grow by $ 485.33 mn during 2022-2026, progressing at a CAGR of 9.19% during the forecast period. This report on the blood-grouping reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic disorders, rise in blood donations, and growing demand for blood transfusions and blood group typing. In addition, the increasing prevalence of chronic disorders is anticipated to boost the growth of the market as well.

The blood-grouping reagents market analysis includes the end-user segment and geographic landscape.

The publisher's blood-grouping reagents market is segmented as below:

By End-user

Hospitals and blood banks
Clinical laboratories
Academic and research institutes

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the emergence of social media marketing as one of the prime reasons driving the blood-grouping reagents market growth during the next few years. Also, emergence of social media marketing, advancement in technology, and increasing penetration of healthcare facilities will lead to sizable demand in the market.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report on blood-grouping reagents market covers the following areas:

Blood-grouping reagents market sizing
Blood-grouping reagents market forecast
Blood-grouping reagents market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood-grouping reagents market vendors that include Agena Bioscience Inc., Alpha Laboratories, Arena BioScien, Atlas Medical GmbH, AXO Science, BAG Health Care GmbH, Beckman Coulter Inc., Bio Rad Laboratories Inc., DIAGAST SAS, Grifols SA, Haemokinesis Ltd., Immucor Inc., Lorne Laboratories Ltd., Medical Diagnostics Corp., Merck KGaA, Novacyt SA, Ortho-Clinical Diagnostics Inc., Quotient Ltd., Rapid Labs Ltd., Torax Biosciences Ltd., and Tulip Diagnostics Pvt. Ltd. Also, the blood-grouping reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user

5.1 Market segments
Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
5.2 Comparison by End-user
Exhibit 26: Chart on Comparison by End-user
Exhibit 27: Data Table on Comparison by End-user
5.3 Hospitals and blood banks - Market size and forecast 2021-2026
Exhibit 28: Chart on Hospitals and blood banks - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Hospitals and blood banks - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Hospitals and blood banks - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Hospitals and blood banks - Year-over-year growth 2021-2026 (%)
5.4 Clinical Laboratories - Market size and forecast 2021-2026
Exhibit 32: Chart on Clinical Laboratories - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Clinical Laboratories - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Clinical Laboratories - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Clinical Laboratories - Year-over-year growth 2021-2026 (%)
5.5 Academic and research institutes - Market size and forecast 2021-2026
Exhibit 36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by End-user
Exhibit 40: Market opportunity by End-user ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.9 Canada - Market size and forecast 2021-2026
Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.10 France - Market size and forecast 2021-2026
Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 Atlas Medical GmbH
Exhibit 89: Atlas Medical GmbH - Overview
Exhibit 90: Atlas Medical GmbH - Product / Service
Exhibit 91: Atlas Medical GmbH - Key offerings
10.4 Bio Rad Laboratories Inc.
Exhibit 92: Bio Rad Laboratories Inc. - Overview
Exhibit 93: Bio Rad Laboratories Inc. - Business segments
Exhibit 94: Bio Rad Laboratories Inc. - Key news
Exhibit 95: Bio Rad Laboratories Inc. - Key offerings
Exhibit 96: Bio Rad Laboratories Inc. - Segment focus
10.5 DIAGAST SAS
Exhibit 97: DIAGAST SAS - Overview
Exhibit 98: DIAGAST SAS - Product / Service
Exhibit 99: DIAGAST SAS - Key offerings
10.6 Grifols SA
Exhibit 100: Grifols SA - Overview
Exhibit 101: Grifols SA - Business segments
Exhibit 102: Grifols SA - Key offerings
Exhibit 103: Grifols SA - Segment focus
10.7 Immucor Inc.
Exhibit 104: Immucor Inc. - Overview
Exhibit 105: Immucor Inc. - Product / Service
Exhibit 106: Immucor Inc. - Key offerings
10.8 Merck KGaA
Exhibit 107: Merck KGaA - Overview
Exhibit 108: Merck KGaA - Business segments
Exhibit 109: Merck KGaA - Key news
Exhibit 110: Merck KGaA - Key offerings
Exhibit 111: Merck KGaA - Segment focus
10.9 Novacyt SA
Exhibit 112: Novacyt SA - Overview
Exhibit 113: Novacyt SA - Business segments
Exhibit 114: Novacyt SA - Key offerings
Exhibit 115: Novacyt SA - Segment focus
10.10 Ortho-Clinical Diagnostics Inc.
Exhibit 116: Ortho-Clinical Diagnostics Inc. - Overview
Exhibit 117: Ortho-Clinical Diagnostics Inc. - Product / Service
Exhibit 118: Ortho-Clinical Diagnostics Inc. - Key offerings
10.11 Quotient Ltd.
Exhibit 119: Quotient Ltd. - Overview
Exhibit 120: Quotient Ltd. - Business segments
Exhibit 121: Quotient Ltd. - Key news
Exhibit 122: Quotient Ltd. - Key offerings
Exhibit 123: Quotient Ltd. - Segment focus
10.12 Rapid Labs Ltd.
Exhibit 124: Rapid Labs Ltd. - Overview
Exhibit 125: Rapid Labs Ltd. - Product / Service
Exhibit 126: Rapid Labs Ltd. - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 127: Inclusions checklist
11.3 Currency conversion rates for US$
Exhibit 128: Currency conversion rates for US$
11.4 Research methodology
Exhibit 129: Research methodology
Exhibit 130: Validation techniques employed for market sizing
Exhibit 131: Information sources
11.5 List of abbreviations
Exhibit 132: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on End-user - Market share 2021-2026 (%)
Exhibits 25: Data Table on End-user - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by End-user
Exhibits 27: Data Table on Comparison by End-user
Exhibits 28: Chart on Hospitals and blood banks - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Hospitals and blood banks - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Hospitals and blood banks - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Hospitals and blood banks - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Clinical Laboratories - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Clinical Laboratories - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Clinical Laboratories - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Clinical Laboratories - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
Exhibits 40: Market opportunity by End-user ($ million)
Exhibits 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 44: Chart on Geographic comparison
Exhibits 45: Data Table on Geographic comparison
Exhibits 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 82: Market opportunity By Geographical Landscape ($ million)
Exhibits 83: Impact of drivers and challenges in 2021 and 2026
Exhibits 84: Overview on Criticality of inputs and Factors of differentiation
Exhibits 85: Overview on factors of disruption
Exhibits 86: Impact of key risks on business
Exhibits 87: Vendors covered
Exhibits 88: Matrix on vendor position and classification
Exhibits 89: Atlas Medical GmbH - Overview
Exhibits 90: Atlas Medical GmbH - Product / Service
Exhibits 91: Atlas Medical GmbH - Key offerings
Exhibits 92: Bio Rad Laboratories Inc. - Overview
Exhibits 93: Bio Rad Laboratories Inc. - Business segments
Exhibits 94: Bio Rad Laboratories Inc. - Key news
Exhibits 95: Bio Rad Laboratories Inc. - Key offerings
Exhibits 96: Bio Rad Laboratories Inc. - Segment focus
Exhibits 97: DIAGAST SAS - Overview
Exhibits 98: DIAGAST SAS - Product / Service
Exhibits 99: DIAGAST SAS - Key offerings
Exhibits 100: Grifols SA - Overview
Exhibits 101: Grifols SA - Business segments
Exhibits 102: Grifols SA - Key offerings
Exhibits 103: Grifols SA - Segment focus
Exhibits 104: Immucor Inc. - Overview
Exhibits 105: Immucor Inc. - Product / Service
Exhibits 106: Immucor Inc. - Key offerings
Exhibits 107: Merck KGaA - Overview
Exhibits 108: Merck KGaA - Business segments
Exhibits 109: Merck KGaA - Key news
Exhibits 110: Merck KGaA - Key offerings
Exhibits 111: Merck KGaA - Segment focus
Exhibits 112: Novacyt SA - Overview
Exhibits 113: Novacyt SA - Business segments
Exhibits 114: Novacyt SA - Key offerings
Exhibits 115: Novacyt SA - Segment focus
Exhibits 116: Ortho-Clinical Diagnostics Inc. - Overview
Exhibits 117: Ortho-Clinical Diagnostics Inc. - Product / Service
Exhibits 118: Ortho-Clinical Diagnostics Inc. - Key offerings
Exhibits 119: Quotient Ltd. - Overview
Exhibits 120: Quotient Ltd. - Business segments
Exhibits 121: Quotient Ltd. - Key news
Exhibits 122: Quotient Ltd. - Key offerings
Exhibits 123: Quotient Ltd. - Segment focus
Exhibits 124: Rapid Labs Ltd. - Overview
Exhibits 125: Rapid Labs Ltd. - Product / Service
Exhibits 126: Rapid Labs Ltd. - Key offerings
Exhibits 127: Inclusions checklist
Exhibits 128: Currency conversion rates for US$
Exhibits 129: Research methodology
Exhibits 130: Validation techniques employed for market sizing
Exhibits 131: Information sources
Exhibits 132: List of abbreviations

Executive Summary

The following companies as the key players in the global blood-grouping reagents market: Bio-Rad Laboratories Inc., DIAGAST, Grifols SA, Immucor Inc., Merck KGaA, Novacyt SA, Ortho-Clinical Diagnostics Inc., Quotient Ltd., Rapid Labs Ltd., and Ybio Inc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the advancement in technology.”

According to the report, one of the major drivers for this market is the growing demand for blood transfusions and blood group typing.

Further, the report states that one of the major factors hindering the growth of this market is the risk associated with blood transfusion.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.